Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication
Open Access
- 1 January 2009
- journal article
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 44 (2), 119-124
- https://doi.org/10.3164/jcbn.08-220r
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 39 references indexed in Scilit:
- Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA MutationAntimicrobial Agents and Chemotherapy, 2009
- Gatifloxacin‐based triple therapy as a third‐line regimen for Helicobacter pylori eradicationJournal of Gastroenterology and Hepatology, 2008
- When should liver biopsy be performed after hematopoietic stem cell transplantation?Journal of Gastroenterology and Hepatology, 2008
- Rapid Detection of Point Mutations Conferring Resistance to Fluoroquinolone in gyrA of Helicobacter pylori by Allele-Specific PCRJournal of Clinical Microbiology, 2007
- Helicobacter pylori: present status and future prospects in JapanThe Esophagus, 2007
- Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance?Alimentary Pharmacology & Therapeutics, 2006
- Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in JapanHelicobacter, 2006
- Gatifloxacin Resistance and Mutations in gyrA after Unsuccessful Helicobacter pylori Eradication in JapanAntimicrobial Agents and Chemotherapy, 2006
- Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failureAlimentary Pharmacology & Therapeutics, 2005
- Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.Diagnostic Microbiology and Infectious Disease, 2001